PMC:7242012 / 8963-9708
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 253 | 430-434 | Gene | denotes | IL‐6 | Gene:3569 |
| 254 | 297-307 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 255 | 576-594 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 256 | 598-609 | Chemical | denotes | chloroquine | MESH:D002738 |
| 257 | 379-387 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 258 | 512-530 | Disease | denotes | cardiac arrythmias | MESH:D001145 |
| 259 | 627-635 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T29 | 336-346 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
| T30 | 451-465 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T89 | 379-387 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T90 | 627-635 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 39-40 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T83 | 65-66 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T84 | 309-310 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T85 | 637-638 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T86 | 735-737 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 297-307 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T11 | 326-335 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T12 | 336-346 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
| T13 | 347-354 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
| T14 | 430-432 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T16 | 576-594 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T17 | 598-609 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 0-233 | Sentence | denotes | The search for effective therapies and a vaccine is occurring at a remarkable pace, with at least 29 studies of therapeutic agents and 5 studies of candidate vaccines registered on ClinicalTrials.org (https://www.clinicaltrials.gov). |
| T117 | 234-388 | Sentence | denotes | On May 1, 2020, the FDA granted Emergency Use Authorization of remdesivir, a broad‐spectrum antiviral nucleotide prodrug for treatment of severe COVID‐19. |
| T118 | 389-482 | Sentence | denotes | Studies of monoclonal antibodies against IL‐6 and hyperimmune immunoglobulin are in progress. |
| T119 | 483-636 | Sentence | denotes | Following reports of serious cardiac arrythmias, the FDA cautioned clinicians of prescribing hydroxychloroquine or chloroquine for treatment of COVID‐19. |
| T120 | 637-745 | Sentence | denotes | A safe and effective vaccine, if successfully developed, probably will not be available for 12 to 18 months. |